NCT01910090View on ClinicalTrials.gov

Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Healthy
Interventions
DRUG

FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET

MULTI-LAYER TABLET

DRUG

ANTADYS® 100 mg, PEPCID® 20 mg

ANTADYS® 100 mg, PEPCID® 20 mg two tablets, taken once

Trial Locations (1)

00962

Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman

Sponsors
All Listed Sponsors
lead

Pharmaceutical Research Unit, Jordan

OTHER